VGN-R09b

· Shanghai Vitalgen BioPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VGN-R09b, covering 2026-03-31 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency [Phase 2, Phase 3]